跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Aldrox - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Aldrox
Approved
STANDARD
Aldrox
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
069a091d89a4618b
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
069a091d89a4618b
Drug Approval Philippines Name
Aldrox
Product Name
Aldrox
Registration Number
DRP-6836-02
Brand Name
Aldrox
Generic Name
Aluminum Hydroxide + Magnesium Hydroxide + Simethicone
Dosage Form
Suspension
Dosage Strength
225 mg/200 mg/25 mg per 5 mL
Manufacturer
Lloyd Laboratories, Inc.
Trader
D.B. Manix International, Inc.
Distributor
Wecare Pharma Corp.
Issuance Date
27 September 2024
Expiry Date
17 August 2029
Pharmacologic Category
Antacid
Classification
Over-The-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
069a091d89a4618b
Type
Standard
Back to Philippines FDA Approvals